Key result
Among 80 patients with nonstaphylococcal CIED-related infections, the overall mortality rate was 4%, and inappropriate antimicrobial coverage was initially provided in about 50% of cases.
Observational (n=80)
Yes
Nonstaphylococcal CIED infections are prevalent (16%) and can involve secondary seeding, highlighting the need for broad-spectrum empirical coverage including Gram-negative bacteria.
Answers are grounded in this paper and cite their sources.
Initial inappropriate coverage in half of nonstaphylococcal CIED infections may support broader empirical regimens; leaves open survival impact in larger studies.
BACKGROUND: Along with the rising use of cardiac implantable electronic devices (CIEDs), there has been a disproportional increase in the number of infections of such devices. Little is known about nonstaphylococcal CIED-related infections, which make up approximately 10% to 30% of all CIED infections. METHODS AND RESULTS: A retrospective review of hospital records of patients admitted with a CIED-related infection was conducted in 4 academic hospitals in Houston, Tex, between 2002 and 2009. Of the 504 identified patients with CIED-related infection, 80 (16%) had a nonstaphylococcal infection and were the focus of this study. The mean duration of CIED placement before infection was 109+/-27 weeks, whereas 44% had their device previously manipulated within a mean of 29.5+/-6 weeks. The mean duration of clinical symptoms before admission was 48+/-12.8 days. Furthermore, 13 patients (16%) presented with CIED-related endocarditis. Although not described in prior reports, we identified 3 definite and 2 suspected cases of secondary Gram-negative bacteria seeding of the CIED. Inappropriate antimicrobial coverage was provided in approximately 50% of the cases with a mean period of 2.1 days. The overall mortality rate was 4%. CONCLUSIONS: Nonstaphylococcal CIED-related infections are prevalent and diverse with a relatively low virulence and mortality rate. Because nonstaphylococcal organisms are capable of secondarily seeding the CIED, a high suspicion for CIED-related infection is warranted in patients with bloodstream infection. In patients with suspected CIED infection, adequate Gram-positive and Gram-negative antibacterial coverage should be administered until microbiological data become available.
No takes yet. Share an insight, caveat, or question.
Viola et al. (2010) conducted an observational in Nonstaphylococcal cardiac implantable electronic device (CIED) infections (n=80). Nonstaphylococcal CIED-related infection was evaluated on Overall mortality. Among 80 patients with nonstaphylococcal CIED-related infections, the overall mortality rate was 4%, and inappropriate antimicrobial coverage was initially provided in about 50% of cases.
Synapse has enriched 10 related papers. Consider them for comparative context: